Treatment with PIK-III led to the accumulation of the autophagy substrates, NBR1, NCOA4 and SQSTM1/p62 confirming inhibition of autophagy in CD34+ CML cells (Figure S6A-B). The gene discussed is SQSTM1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.